Ye Sun

Ye Sun represents issuers and underwriters in the Hong Kong IPO market, particularly in the healthcare sector. He also represents issuers and underwriters in U.S. IPOs and U.S.-Hong Kong dual listings, and advises large corporations, private equity funds, and financial advisors on M&A and general corporate matters. In the past year alone, Ye has served as lead lawyer on more than a half-dozen completed IPOs and approximately twenty ongoing IPO projects. Ye is fluent in both Mandarin and English.

Capital Markets

• Cryofocus Medtech (Shanghai) Co., Ltd. in its IPO and listing on the Hong Kong Stock Exchange
• Sipai Health Technology Co., Ltd. in its IPO and listing on the Hong Kong Stock Exchange
• Jenscare Scientific Co., Ltd. in its IPO and listing on the Hong Kong Stock Exchange
• Yonghe Medical Group Co., Ltd. in its US$206 million IPO and listing on the Hong Kong Stock Exchange
• Shanghai Bio-heart Biological Technology Co., Ltd. in its US$65.3 million IPO and listing on the Hong Kong Stock Exchange
• Acotec Scientific Holdings Limited in its US$210 million IPO and listing on the Hong Kong Stock Exchange
• Goldman Sachs (Asia) L.L.C. and China International Capital Corporation Hong Kong Securities Limited and other underwriters in the US$145 million IPO and listing of Shanghai HeartCare Medical Technology Corporation Limited on the Hong Kong Stock Exchange
• J.P. Morgan, BofA Securities, CICC and Haitong International as joint sponsors and other underwriters in the approximately US$1.92 billion secondary listing of GDS Holdings Limited on the Hong Kong Stock Exchange
• Peijia Medical Limited in its US$343 million IPO and listing on the Hong Kong Stock Exchange
• Honliv Healthcare Management Group Company Limited in its US$42 million IPO and listing on the Hong Kong Stock Exchange
• Yeahka Limited in its US$212 million IPO and listing on the Hong Kong Stock Exchange
• Aesthetic Medical International Holdings in its US$34.5 million IPO on the Nasdaq
• Guotai Junan Capital as sole sponsor and Guotai Junan Securities (Hong Kong) as main underwriter, and other underwriters in the US$65 million IPO and listing of Zhongguancun Science-Tech Leasing on the Hong Kong Stock Exchange
• Fortune Financial Capital as sole sponsor, Fortune Securities, CICC as joint global coordinators and other underwriters in the US$65.3 million primary listing of Zero2IPO Holdings Inc. on the Hong Kong Stock Exchange
• First Shanghai Capital as sole sponsor and First Shanghai Securities as sole global coordinator, and other underwriters in the US$70 Million IPO and listing of Chen Lin Education Group on the Hong Kong Stock Exchange
• Inke Limited in its US$140 million IPO and listing of shares on the Hong Kong Stock Exchange
• China International Capital Corporation, ICBC International and Macquarie as representatives of the underwriters in the US$35 million IPO and listing of shares on the Hong Kong Stock Exchange by Wanka Online Inc.
• Goldman Sachs, Deutsche Bank and Citigroup as representatives of the underwriters in the US$44 million IPO and listing of American Depositary Shares on NASDAQ by Pintec Technology Holdings Limited
• Goldman Sachs, Morgan Stanley, J.P. Morgan and China Renaissance as representatives of the underwriters in the US$180 million IPO and listing of American Depositary Shares on NASDAQ by Jianpu Technology Inc.
• 3SBio Inc. in its US$700 million IPO of shares on the Hong Kong Stock Exchange
• Morgan Stanley, Credit Suisse, BofA Merrill Lynch and Jefferies as representatives of the underwriters in the US$362 million SEC-registered follow-on offering of common stock by China Biologic Products, Inc.
• Zhaopin Limited in its US$75.7 million IPO and listing of its American Depositary Shares on the NYSE
• Yirendai Limited in its US$75.0 million IPO and listing of its American Depositary Shares on NASDAQ